RSV, A MOSTLY UNKNOWN PUBLIC HEALTH MENACE

-

 

RSV, A MOSTLY UNKNOWN PUBLIC HEALTH MENACE




As the Centers for Disease Control and Prevention (CDC) determines whether to approve a vaccine against RSV for adults 60 and older, a new survey from the Annenberg Public Policy Center finds that the American public is ill-informed about the virus, unfamiliar with its most common symptoms, and more hesitant to recommend the vaccine to pregnant people than to older adults.

RSV is the leading cause of lower respiratory tract infections in babies worldwide. Though its symptoms are typically mild, the highly contagious RSV, or respiratory syncytial virus, can cause serious illness, hospitalization, and even death among infants and the elderly. By age 2, nearly all children get sick from RSV, one of three illnesses -- with the flu and Covid-19 -- contributing to last winter's "tripledemic" that overwhelmed some healthcare facilities. The CDC estimates that 58,000 to 80,000 children under age 5 are hospitalized annually because of it.

After decades of research, scientists have developed vaccines against RSV. In May, the Food and Drug Administration (FDA) approved two RSV vaccines for older adults, and this summer is likely to support a maternal RSV vaccine for pregnant people to pass antibodies on to fetuses to prevent RSV in infants from birth up to at least six months of age.

The survey of more than 1,600 adults finds that less than half of Americans (49%) were likely to recommend the vaccine against RSV if approved by the FDA to a pregnant friend or family member. By contrast, most Americans (63%) would suggest a vaccine against RSV to a friend or family member aged 65 or older. (When the survey was fielded, the FDA approved the vaccine for adults 60 and older, although the shots were unavailable.)

"Those who recall the stress that the tripledemic placed on the nation's hospitals last fall will understand why older individuals and those who are pregnant should discuss the advisability of RSV vaccination with their health care providers," said Kathleen Hall Jamieson, director of the Annenberg Public Policy Center (APPC) of the University of Pennsylvania and director of the study.

APPC's Annenberg Science and Public Health Knowledge survey

The survey data come from the 11th wave of a nationally representative panel of 1,601 U.S. adults, first empaneled in April 2021, conducted for the Annenberg Public Policy Center by SSRS, an independent market research company. This wave of the Annenberg Science and Public Health Knowledge (ASAPH) survey was fielded May 31-June 6, 2023, with a margin of sampling error (MOE) of ± 3.3 percentage points at the 95% confidence level.

Download the topline and the methodology.

Data from earlier waves on Covid-19, society's "return to normal," vaccination, monkeypox, the seasonal flu, health misinformation, and related topics can be found here.

Underestimating the prevalence of RSV -- but awareness of potential severity.

A quarter of the public (27%) expresses worry about contracting or having a family member contract RSV, less than the one-third (33%) who were worried in our January survey conducted during the tripled emic. The decrease in concern is not surprising given that RSV circulates during the fall and winter, and there was media coverage of the surge of cases last winter that filled some hospitals, combined with flu and Covid-19 cases.

The prevalence of this common illness is vastly underestimated by the public. Only 22% in the current survey say they know children who have had RSV -- and among these respondents, over half say they have known just one or two children who have had it. Asked how many children contract RSV before age two, 2% of respondents say, "virtually all." According to the CDC, "Almost all children will have had an RSV infection by their second birthday."

But its potential severity is evident among the people who say they know children who have had RSV. Over half (54%) of these respondents say the illness was somewhat serious. "Most children with cold-like symptoms are not tested for RSV, but when a child becomes severely ill, it's more likely that child will undergo diagnostic testing," Jamieson said. While RSV can cause severe illnesses such as bronchiolitis and pneumonia, the CDC says it usually causes mild, cold-like symptoms -- like runny nose, coughing, sneezing, fever, wheezing, and decreased appetite -- and is often mistaken for cold or flu.

This does not mean, however, that some do not experience serious illness. Among 100 babies under the age of six months who get RSV, 1 to 2 may require hospitalization, the CDC says. Although RSV-associated deaths are "uncommon" in the United States, they occur at an estimated rate of 100 to 500 per year for children under five, according to the CDC. Worldwide deaths of children under 5 years old attributable to RSV exceed 100,000 annually.

Far fewer people say they know older adults who have had RSV. Only 6% of those surveyed say they know someone 65 or older who has had RSV. Among this group of respondents, most (71%) say they know one or two people who have had it, and most (72%) say the infection was somewhat or very serious. The CDC reports that among adults 65 and older, 60,000 to 160,000 hospitalizations per year from RSV and 6,000 to 10,000 deaths.

Great uncertainty about RSV

Only small segments of the American public correctly answer questions about RSV. Most people say they are not sure. The survey found that:

  • Symptoms: Less than 1 in 5 people (18%) know it's more accurate to say that RSV usually produces mild, cold-like symptoms than severe difficulties in breathing (38%). And 44% say they are not sure.
  • Persistence: Less than 1 in 5 people (17%) know it's more accurate to say that RSV can survive many hours on hard surfaces such as table or crib rails than RSV can't stay for many hours on these hard surfaces (9%). Most people (75%) say they are not sure.
  • Reoccurrence: Less than 4 in 10 people (38%) know it's more accurate to say that once a person contracts RSV, they can get it again. Only 2% incorrectly believe it's more accurate to say that you can't get RSV again, but 60% say they are unsure.
  • Spreading the virus: Just over 4 in 10 people (42%) know it's more accurate to say it is possible to have and spread RSV before showing symptoms than to say it is not possible (3%). But over half of those surveyed (54%) are still determining.
  • Vaccine for older adults: Just 13% knew when the survey was fielded about the existence of an FDA-approved vaccine against RSV for older adults, while 18% said there was not an FDA-approved vaccine. Nearly 7 in 10 people (69%) said they needed clarification. (The FDA approved one RSV vaccine for adults 60 and older on May 3, 2023, and the second one on May 31, the beginning of the survey period. A CDC committee of experts known as ACIP is meeting today on whether the CDC should recommend those vaccines and, if so, for what ages.)
  • Vaccine for pregnant people: Just 1 in 5 people (20%) knew when the survey was fielded that there was not an FDA-approved vaccine against RSV for those who are pregnant to benefit their newborns, while 7% thought there was one. Nearly three-quarters of those surveyed (73%) needed to be sure. "However," Jamieson noted, "since an FDA advisory panel had recommended approval at that point, we would expect a high level of uncertainty about whether or not an FDA-approved vaccine existed."
  • Vaccine for infants and children: About 1 in 5 people (19%) know there is currently not an FDA-approved vaccine against RSV for infants and children in the United States, while 11% say incorrectly that there is one, and 70% are not sure.

Fewer than half recognize the symptoms of RSV.

Fewer than half of those surveyed recognized some of the most common symptoms of RSV (respondents were asked to select all that applied):

  • Wheezing: 46% know this is a symptom
  • Runny nose: 38% know this is a symptom
  • Pauses in breathing: 33% know this is a symptom
  • Decreased activity: 32% know this is a symptom
  • Reduced appetite: 29% know this is a symptom

Very few people incorrectly selected non-respiratory symptoms as associated with RSV:

  • Jaundiced skin: 5% incorrectly say this is a symptom of RSV
  • Spontaneous bruising: 2% incorrectly say this is a symptom of RSV
  • Bleeding gums: 2% incorrectly say this is a symptom of RSV

The Annenberg Public Policy Center was established in 1993 to educate the public and policymakers about communication's role in advancing public understanding of political, scientific, and health issues at the local, state, and federal levels. Read more about our science and health surveys here.

Comments

Post a Comment

Popular posts from this blog

PEOPLE WITH OBESITY BURN LESS CALORIES DURING THE DAY

-
Image
  PEOPLE WITH OBESITY BURN LESS CALORIES DURING THE DAY Building on prior studies with healthy-weight participants, the new research includes different body sizes.         New research indicates that weight influences how and when bodies burn energy. An Oregon Health & Science University study published in the journal  Obesity  found people who have a healthy weight use more energy during the day, when most people are active and eat, while those who are obese spend more energy during the night when most people sleep. The study also found that during the day, those with obesity have higher levels of the hormone insulin -- a sign that the body is working harder to use glucose, an energy-packed sugar. "It was surprising to learn how dramatically the timing of when our bodies burn energy differed in those with obesity," said the study's first author, Andrew McHill, Ph.D., an assistant professor at the OHSU School of Nursing and the Oregon Institute of ...
Read more

WHAT CAUSES ITCHING, AND WHAT STOPS IT?

-
Image
  WHAT CAUSES ITCHING, AND WHAT STOPS IT?         It can be a relief to scratch the occasional itch, but when itch gets out of control, it can become a severe health problem. How does the body know when to stop? Scientists at UC San Francisco are getting close to an answer. In a breakthrough that could transform how doctors treat conditions from eczema to allergies, they have discovered a feedback loop centered on a single immune protein called IL-31 that causes the urge to itch and dials back nearby inflammation. The findings, published on October 13th in  Science Immunology , lay the groundwork for a new generation of drugs that interact more intelligently with the body's innate self-regulating ability. Previous approaches suggested that IL-31 signals itch and promotes skin inflammation. However, the UCSF team discovered that nerve cells, or neurons, that respond to IL-31, triggering a scratch, also prevent immune cells from overreacting and causing more ...
Read more

A VEGAN DIET IMPROVES CARDIOVASCULAR HEALTH, ACCORDING TO A NEW STUDY

-
Image
  A VEGAN DIET IMPROVES CARDIOVASCULAR HEALTH, ACCORDING TO A NEW STUDY         In a study with 22 pairs of identical twins, Stanford Medicine researchers and their colleagues have found that a vegan diet improves cardiovascular health in as little as eight weeks. Although it's well-known that eating less meat improves cardiovascular health, diet studies often need to be enhanced by genetic differences, upbringing, and lifestyle choices. By studying identical twins, however, the researchers were able to control for genetics and limit the other factors, as the twins grew up in the same households and reported similar lifestyles. "Not only did this study provide a groundbreaking way to assert that a vegan diet is healthier than the conventional omnivore diet, but the twins were also a riot to work with," said Christopher Gardner, Ph.D., the Rehnborg Farquhar Professor and a professor of medicine. "They dressed the same, they talked the same, and they had a banter ...
Read more